Britain approves AstraZeneca's antibody-based COVID-19 therapy - CNA

3/17/2022 12:00:00 AM3 years 1 month ago

Britain's medicines regulator has approved AstraZeneca's antibody-based COVID-19 treatment for adults with poor immune response, marking a major step in the fight against the pandemic as infections surge globally amid spread of the Omicron variant. The dec…

Britain's medicines regulator has approved AstraZeneca's antibody-based COVID-19 treatment for adults with poor immune response, marking a major step in the fight against the pandemic as infections s… [+1628 chars]

full article...